Sensus Healthcare (NASDAQ:SRTS) specializes in developing, manufacturing, and marketing innovative treatments for patients with non-melanoma skin cancers and other skin conditions. Their portfolio includes superficial radiation therapy (SRT) and laser devices that offer non-invasive treatment options to patients, aiming to improve the quality of life for those undergoing treatment for skin conditions. The company's projects focus on expanding the application of their technology to address a broader range of skin issues, with the objective of becoming a comprehensive solution provider in the dermatological treatment space. Sensus Healthcare is committed to advancing dermatological care through continuous innovation and making their treatments accessible to patients globally.